PMID: 2124709Dec 1, 1990Paper

Preparation and crystallization of a human immunodeficiency virus p24-Fab complex

Proceedings of the National Academy of Sciences of the United States of America
A J ProngayJ McClure

Abstract

A recombinant form of human immunodeficiency virus capsid protein, p24, expressed in Escherichia coli has been purified to homogeneity and separated into distinct isoelectric forms. A monoclonal antibody, mAb25.4, which recognizes an epitope in the amino-terminal region of p24, has been purified to homogeneity from ascites fluid and digested with papain to produce the respective antigen-binding fragment (Fab). The Fab25.4 was purified from the digestion mixture and separated into two distinct isoelectric forms. The two Fab species were each complexed with one isoelectric form of the recombinant p24 by incubating equimolar quantities of the two proteins. Two different crystal morphologies of the p24-Fab25.4 complex were obtained by the vapor-diffusion method with 12-24% PEG 3350 as the precipitant. One of these crystal forms has unit-cell parameters of a = 92.1 A, b = 85.4 A, c = 54.0 A, alpha = gamma = 90.0 degrees and beta = 90.4 degrees and belongs to the monoclinic space group P2(1), with one molecule of the complex per asymmetric unit. These crystals strongly diffracted x-rays to at least 2.7-A resolution.

References

Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H TowbinJ Gordon
Oct 1, 1990·AIDS Research and Human Retroviruses·L S EhrlichC A Carter
Apr 9, 1987·Nature·A R CoatesM J Sternberg
Aug 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·G LavieD Meruelo
Nov 5, 1989·Journal of Molecular Biology·S S KimM A McKinlay
Jan 1, 1989·Pharmacology & Therapeutics·G D DianaJ Badger
Aug 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·E A PadlanD R Davies
May 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J BadgerM G Rossmann
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D MerueloD Lavie
Sep 27, 1985·Science·J M HogleD J Filman
Jan 9, 1987·Science·M LuoA C Palmenberg
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·M G Rossmann
Apr 28, 1968·Journal of Molecular Biology·B W Matthews

❮ Previous
Next ❯

Citations

Jul 1, 1992·Medicinal Research Reviews·M D Walkinshaw
Jul 31, 1998·Protein Science : a Publication of the Protein Society·R J CenterP Poumbourios
Jul 3, 1995·Biochimica Et Biophysica Acta·R MisselwitzH Welfle
Apr 30, 2003·Journal of Structural Biology·Glenn E DaleAllan D'Arcy
Jun 30, 2012·Nature Reviews. Drug Discovery·Alastair D G Lawson
Sep 1, 1996·Nature Structural Biology·C MomanyM G Rossmann
Sep 1, 1994·AIDS Research and Human Retroviruses·D Bizub-BenderA M Skalka
Jan 11, 2011·Protein Engineering, Design & Selection : PEDS·Jennifer C PaiJennifer A Maynard
Nov 20, 2009·Acta Crystallographica. Section D, Biological Crystallography·Jeffrey E LeeErica Ollmann Saphire
Jun 9, 2011·Clinical and Experimental Immunology·L Griffin, A Lawson
Jan 18, 2005·Progress in Biophysics and Molecular Biology·Lawrence J DelucasNikolai Chernov
May 7, 2010·Acta Crystallographica. Section D, Biological Crystallography·Zygmunt S Derewenda
Oct 21, 2017·AIMS Biophysics·Joshua HolcombZhe Yang
Jan 10, 2020·Current Opinion in Structural Biology·Peer Re MittlAndreas Plückthun
Feb 5, 1999·Journal of Molecular Biology·Z JinC L Lawson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.